This is a summary of what I thought was a very interesting paper given a few weeks ago at the
2015 Genitourinary Cancers Symposium . It not only discusses the current BCG shortage, what might be done for patients in the interim, but also the current Best Practices for treatment of bladder cancer.
Well worth reading by all patients, and not too technical.
gucasym.org/alternatives-bcg-immunotherapy-bladder-cancer-treatment-during-drug-shortages
Sara Anne
